Jump to content

Draft:Preceptis Medical

From Wikipedia, the free encyclopedia

Preceptis Medical is a medical device company based in Plymouth, Minnesota, specializing in pediatric tympanostomy tubes. The company's flagship product is the Hummingbird Tympanostomy Tube System, noted for being one of the only ear tubes that can be inserted without general anesthesia.

History

[edit]

Preceptis was founded in 2011 as a startup.[1] In 2013, Preceptis won the grand prize at The Minnesota Cup, a competition that awards innovative business ideas.[2]

In 2020, it was granted FDA clearance for children 6 to 24 months of age, allowing for the device to place ear tubes without general anesthesia.[3][4]

In 2021, a clinical study "affirmed an in‐office alternative for clinicians and parents who have concerns with the risk, inconvenience and cost of surgery in an operating room under general anesthesia."[5]

In 2022, the FDA cleared it to be used in all children 6 months old and older.[6][7]

In 2024, the Centers for Medicare & Medicaid Services assigned a Healthcare Common Procedure Coding System (HCPCS) code to the Hummingbird TTS procedure. This coding supports the adoption of the Hummingbird system by providing clear reimbursement pathways for ENT specialists.[8]

Funding

[edit]

Preceptis raised $1.2 million from Minneapolis investing group Gopher Angels in 2014 and $3 million in financing in 2016. It raised $3.6 million during a Series B that concluded in March of 2020.[9]

Lack of general anesthesia

[edit]

The Hummingbird is notable for the lack of general anesthesia,[10] instead only requiring the eardrum to be numbed.[11] According to various news reports and medical professionals, the alternative general anesthesia is the most important differentiator of the Hummingbird.[12][13]

References

[edit]
  1. ^ Schaust, Sam (9 August 2017). "Preceptis Medical is Seeking $1M". Twin Cities Business.
  2. ^ "Minnesota Cup Names 2013 Grand Prize Winner Of $65K". Twin Cities Business. 22 September 2013.
  3. ^ Brenner, M. J.; Shenson, J. A.; Rose, A. S.; Valdez, T. A.; Takashima, M.; Ahmed, O. G.; Weissbrod, P. A.; Hong, R. S.; Djalilian, H.; Wolf, J. S.; Morrison, R. J.; Santa Maria, P. L.; Erbele, I. D. (2021). "New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review 2020". Oto Open. 5 (4): 2473974X211057035. doi:10.1177/2473974X211057035. PMC 8591653. PMID 34790883.
  4. ^ "US Food & Drug Administration" (PDF). fda.gov.
  5. ^ Truitt, T. O.; Kosko, J. R.; Nimmons, G. L.; Raisen, J.; Skovlund, S. M.; Rimell, F.; Cofer, S. A. (2021). "In-office insertion tympanostomy tubes in children using single-pass device". Laryngoscope Investigative Otolaryngology. 6 (2): 325–331. doi:10.1002/lio2.533. PMC 8035945. PMID 33869765.
  6. ^ Weldon, Ross. "FDA clears ear tube device for all children aged 6 months or older". Healio.
  7. ^ Fink, Jennifer. "New Products May Change the Way Tympanostomy Tubes Are Placed". ENT Today.
  8. ^ "Preceptis Medical Announces New CMS HCPCS Code for Pediatric Tympanostomy Procedures". AP News. 5 November 2024.
  9. ^ Miller, Carrigan. "Preceptis Medical raises $3.8M after 'Hummingbird' gets FDA clearance". Biz Journals.
  10. ^ "'Hummingbird' Is Game Changer For Costly Ear Tube Procedures". CBS News. 15 June 2021.
  11. ^ "In-office, ear tube procedure reduces stress and adverse effects". Mayo Clinic.
  12. ^ Guertin, Riley (6 September 2024). "Living Well: How the Hummingbird Procedure is changing the medical game". News 40 WNKY.
  13. ^ CBS News. "Medical Minute: Ear Tubes". News 9.